WCN26-4702 USE OF LAXATIVES BY CKD STAGE AND SERUM MAGNESIUM MEASUREMENT STATUS DURING USE OF MAGNESIUM-CONTAINING LAXATIVES

Read full text Summarise with VIRAT
Authors: Asuka Sakakimoto, Kazuo TAKI, Kazufumi Tanabe, Shinichi ARAKI
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Constipation is an important symptom that frequently occurs in patients with chronic kidney disease (CKD), and effective treatment of constipation is necessary to maintain quality of life. Magnesium (Mg)-containing laxatives are generally the most frequently used, but concerns have been raised about the accumulation of serum magnesium associated with deteriorating kidney function. To avoid abnormal serum Mg accumulation, serum Mg levels must be monitored and the dose adjusted as necessary. However, it is unclear which laxatives are prescribed for patients at each stage of CKD and how many patients prescribed Mg-containing laxatives have their serum Mg levels measured at least once a year in clinical practice.

Fields of Study & Subjects

Gastrointestinal motility and disorders Magnesium in Health and Disease Dialysis and Renal Disease Management

Publication details

Journal / source
Kidney International Reports
Volume
11
Issue
4
Pages
104228–104228
Publication date
25 March 2026
Language
EN